Placeholder Banner

New Online IP Marketplace Will Foster Collaboration in Race to Eradicate COVID-19

May 4, 2020
Media Contact
Vicky Stinson

To help in the response to the coronavirus pandemic, the U.S. Patent and Trademark Office today launched a new online platform, called “Patents 4 Partnerships,” to share patent information for various technologies to facilitate greater collaboration across industries. Tom DiLenge, President of BIO’s Advocacy, Law & Public Policy Division, issued the following statement in response:

“The U.S. Patent and Trademark Office has taken an important step to support critical research collaboration during this pandemic. Our nation’s intellectual property protections provide a strong foundation for the rapid response against COVID-19, as thousands of scientists in hundreds of biopharmaceutical companies work around the clock to develop treatments and vaccines for this deadly virus. Our researchers are working together like never before, sharing knowledge and resources to accelerate R&D solutions. And all of this collaboration is possible because of the strong intellectual property system we have in place today, not in spite of it. 

“To advance the discovery of life-saving medicines, the biopharmaceutical industry is committed to robust collaboration both across the industry and with public and nonprofit partners. This new online platform will help us achieve our shared goal of eradicating COVID-19 as quickly as possible.”  

Learn more about some of the latest scientific advancements in the fight against COVID-19 at


Discover More
Stephanie Batchelor, vice president of BIO's Industrial and Environmental Section, released the following statement in reaction to the Trump administration's move to issue Renewable Fuel Standard (RFS) waivers for the 2019 compliance year. “This…
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…
Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), today applauded the Food and Drug Administration (FDA) for publicly releasing new guidance related to the emergency use authorization of future…